JPWO2023102490A5 - - Google Patents
Info
- Publication number
- JPWO2023102490A5 JPWO2023102490A5 JP2024532709A JP2024532709A JPWO2023102490A5 JP WO2023102490 A5 JPWO2023102490 A5 JP WO2023102490A5 JP 2024532709 A JP2024532709 A JP 2024532709A JP 2024532709 A JP2024532709 A JP 2024532709A JP WO2023102490 A5 JPWO2023102490 A5 JP WO2023102490A5
- Authority
- JP
- Japan
- Prior art keywords
- formula
- sirna molecule
- represented
- nucleotides
- epilepsy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163284932P | 2021-12-01 | 2021-12-01 | |
| US63/284,932 | 2021-12-01 | ||
| PCT/US2022/080766 WO2023102490A1 (en) | 2021-12-01 | 2022-12-01 | Compositions and methods for treatment of epilepsies |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024542728A JP2024542728A (ja) | 2024-11-15 |
| JPWO2023102490A5 true JPWO2023102490A5 (https=) | 2025-12-08 |
| JP2024542728A5 JP2024542728A5 (https=) | 2025-12-08 |
Family
ID=86613118
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024532709A Pending JP2024542728A (ja) | 2021-12-01 | 2022-12-01 | てんかんの治療のための組成物及び方法 |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP4441229A1 (https=) |
| JP (1) | JP2024542728A (https=) |
| KR (1) | KR20240159663A (https=) |
| CN (1) | CN118974255A (https=) |
| AU (1) | AU2022402159A1 (https=) |
| CA (1) | CA3241122A1 (https=) |
| MX (1) | MX2024006709A (https=) |
| WO (1) | WO2023102490A1 (https=) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2019218987B2 (en) * | 2018-02-12 | 2025-04-24 | Ionis Pharmaceuticals, Inc. | Modified compounds and uses thereof |
| US20220056455A1 (en) * | 2018-12-20 | 2022-02-24 | Praxis Precision Medicines, Inc. | Compositions and methods for the treatment of kcnt1 related disorders |
| PE20220168A1 (es) * | 2019-03-15 | 2022-01-28 | Ionis Pharmaceuticals Inc | Compuestos y metodos para reducir la expresion de kcnt1 |
-
2022
- 2022-12-01 MX MX2024006709A patent/MX2024006709A/es unknown
- 2022-12-01 KR KR1020247021913A patent/KR20240159663A/ko active Pending
- 2022-12-01 AU AU2022402159A patent/AU2022402159A1/en active Pending
- 2022-12-01 CA CA3241122A patent/CA3241122A1/en active Pending
- 2022-12-01 CN CN202280090018.8A patent/CN118974255A/zh active Pending
- 2022-12-01 JP JP2024532709A patent/JP2024542728A/ja active Pending
- 2022-12-01 WO PCT/US2022/080766 patent/WO2023102490A1/en not_active Ceased
- 2022-12-01 EP EP22902402.1A patent/EP4441229A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016530882A5 (https=) | ||
| CN110832077B (zh) | 用于抑制α-ENaC表达的RNAi剂及使用方法 | |
| JP7384033B2 (ja) | 一本鎖オリゴヌクレオチド | |
| CN104321334A (zh) | 三环核苷及由其制备的低聚化合物 | |
| TW202329983A (zh) | Ｒｎａ編輯 | |
| JPWO2023102490A5 (https=) | ||
| CN119698475A (zh) | 血管紧张素原的高效rna靶向(arnatar) | |
| WO2020038973A1 (en) | Antisense oligonucleotides targeting sptlc1 | |
| JP2022514648A (ja) | Ｃａｒｄ９を標的とするアンチセンスオリゴヌクレオチド | |
| JPWO2023102488A5 (https=) | ||
| TW202309286A (zh) | 作為新穎基因靜默技術的非對稱短雙股ｄｎａ及其應用 | |
| JP7725370B2 (ja) | Ａｎｇｐｔｌ２アンチセンスオリゴヌクレオチドおよびその使用 | |
| TW202313977A (zh) | 作為新穎基因靜默技術的短雙股ｄｎａ及其應用 | |
| JPWO2022204430A5 (https=) | ||
| WO2022266486A2 (en) | Products and compositions | |
| JPWO2020190740A5 (https=) | ||
| JPWO2022250155A5 (https=) | ||
| JPWO2022204429A5 (https=) | ||
| JP2024546887A (ja) | オリゴヌクレオチドｇｂａアゴニスト | |
| HK40111119A (zh) | 寡核苷酸gba激动剂 | |
| CN118541484A (zh) | 反义寡核苷酸 | |
| EP4705457A2 (en) | Oligonucleotides capable of upregulating glucocerebrosidase expression | |
| WO2024229229A2 (en) | Products and compositions | |
| WO2020038971A1 (en) | Antisense oligonucleotides targeting vcan | |
| CN119365600A (zh) | 靶向颗粒蛋白前体的反义寡核苷酸 |